These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15187149)

  • 1. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family.
    Ernst S; Lange C; Wilbers A; Goebeler V; Gerke V; Rescher U
    J Immunol; 2004 Jun; 172(12):7669-76. PubMed ID: 15187149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
    Rabiet MJ; Huet E; Boulay F
    Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR.
    Walther A; Riehemann K; Gerke V
    Mol Cell; 2000 May; 5(5):831-40. PubMed ID: 10882119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
    Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
    J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.
    Migeotte I; Riboldi E; Franssen JD; Grégoire F; Loison C; Wittamer V; Detheux M; Robberecht P; Costagliola S; Vassart G; Sozzani S; Parmentier M; Communi D
    J Exp Med; 2005 Jan; 201(1):83-93. PubMed ID: 15623572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics.
    Perretti M; Getting SJ; Solito E; Murphy PM; Gao JL
    Am J Pathol; 2001 Jun; 158(6):1969-73. PubMed ID: 11395373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
    Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
    J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
    de Paulis A; Montuori N; Prevete N; Fiorentino I; Rossi FW; Visconte V; Rossi G; Marone G; Ragno P
    J Immunol; 2004 Nov; 173(9):5739-48. PubMed ID: 15494526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
    Karlsson J; Fu H; Boulay F; Dahlgren C; Hellstrand K; Movitz C
    J Leukoc Biol; 2005 Sep; 78(3):762-71. PubMed ID: 15951351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes.
    Sawmynaden P; Perretti M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1351-5. PubMed ID: 16973129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional expression of formyl peptide receptor family in human NK cells.
    Kim SD; Kim JM; Jo SH; Lee HY; Lee SY; Shim JW; Seo SK; Yun J; Bae YS
    J Immunol; 2009 Nov; 183(9):5511-7. PubMed ID: 19843937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct.
    Gavins FN; Kamal AM; D'Amico M; Oliani SM; Perretti M
    FASEB J; 2005 Jan; 19(1):100-2. PubMed ID: 15507472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.
    Gavins FN; Yona S; Kamal AM; Flower RJ; Perretti M
    Blood; 2003 May; 101(10):4140-7. PubMed ID: 12560218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.
    Hayhoe RP; Kamal AM; Solito E; Flower RJ; Cooper D; Perretti M
    Blood; 2006 Mar; 107(5):2123-30. PubMed ID: 16278303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiflammin-2 activates the human formyl-peptide receptor like 1.
    Kamal AM; Hayhoe RP; Paramasivam A; Cooper D; Flower RJ; Solito E; Perretti M
    ScientificWorldJournal; 2006 Oct; 6():1375-84. PubMed ID: 17072491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of annexin-1 in equine leucocytes and the effects of the N-terminal annexin-1 peptide, Ac2-26, on equine neutrophil superoxide production.
    Pickles KJ; Brooks AC; Rickards KJ; Cunningham FM
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):226-33. PubMed ID: 20079938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation.
    Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ
    J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.
    John CD; Sahni V; Mehet D; Morris JF; Christian HC; Perretti M; Flower RJ; Solito E; Buckingham JC
    FASEB J; 2007 Apr; 21(4):1037-46. PubMed ID: 17218541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling.
    Zhang S; Gong H; Ge Y; Ye RD
    Pharmacol Res; 2020 Nov; 161():105117. PubMed ID: 32768626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.